Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesenchymal stem cells and gene therapy.

A I Caplan1

  • 1Skeletal Research Center, Biology Department, Case Western Reserve University, Cleveland, OH 44106-7080, USA.

Clinical Orthopaedics and Related Research
|October 20, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human bone marrow-derived mesenchymal stem cells rescue neonatal CPAP-induced airway hyperreactivity.

Respiratory physiology & neurobiology·2022
Same author

Improving the regulatory framework for cell therapy does not equate to deregulation.

CellR4-- repair, replacement, regeneration, & reprogramming·2021
Same author

Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).

CellR4-- repair, replacement, regeneration, & reprogramming·2021
Same author

Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation.

Osteoarthritis and cartilage·2014
Same author

Myogenic Expression of Mesenchymal Stem Cells within Myotubes of mdx Mice in Vitro and in Vivo.

Tissue engineering·2009
Same author

Construction of a bilayered dermal equivalent containing human papillary and reticular dermal fibroblasts: use of fluorescent vital dyes.

Tissue engineering·2009
Same journal

Which Factors Are Associated With Death, Local Recurrence, and Perioperative Complications After En Bloc Resection for Primary Malignant Tumors of the Mobile Spine?

Clinical orthopaedics and related research·2026
Same journal

Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study.

Clinical orthopaedics and related research·2026
Same journal

What Is the Effect of Robot Reduction in Displaced Pelvic Fractures? A Multicenter Randomized Clinical Trial.

Clinical orthopaedics and related research·2026
Same journal

CORR Insights®: Acute or Delayed TKA for Tibial Plateau Fracture? An Observational Study From the Swedish Arthroplasty Register.

Clinical orthopaedics and related research·2026
Same journal

Reply to the Letter to the Editor: Guest Editorial: Recalling a Recall.

Clinical orthopaedics and related research·2026
Same journal

Radial Head Fractures Cluster in the Anterolateral and Anteromedial Quadrants and Do Not Correlate With Coronoid Fracture Types.

Clinical orthopaedics and related research·2026
See all related articles

Multipotent mesenchymal stem cells from human bone marrow can be greatly expanded and genetically modified without losing their stem cell properties. This makes them promising for treating genetic disorders affecting skeletal tissues.

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Genetic engineering

Background:

  • Multipotent human mesenchymal stem cells (hMSCs) are found in bone marrow.
  • These cells possess significant expansion potential in vitro.
  • hMSCs maintain their stemness after extensive cell culture.

Purpose of the Study:

  • To assess the expansion capacity of hMSCs.
  • To evaluate the feasibility of genetically modifying hMSCs.
  • To determine if genetic modification affects hMSC stem cell capacity.

Main Methods:

  • Isolation and expansion of hMSCs from bone marrow.
  • Transduction of hMSCs with genes for reporter molecules and cytokines.
  • Assessment of stem cell capacity post-transduction.

Related Experiment Videos

Main Results:

  • hMSCs can be expanded over a billion-fold.
  • Genetic transduction of hMSCs is achievable.
  • Gene insertion does not compromise the stem cell capacity of hMSCs.

Conclusions:

  • Human mesenchymal stem cells exhibit remarkable expansion potential.
  • Genetic modification of hMSCs is feasible without affecting their stemness.
  • hMSCs are a viable candidate for cell-based therapies in skeletal genetic disorders.